Conclusion
Over the past ten years, overall OAC prescribing increased by one-third.
By 2018, 55.2% of the patients with a high stroke risk had an OAC
prescription recorded, with the proportion varying substantially between
practices. There remains scope to improve OAC prescribing for AF in the
primary care setting, and the reasons for withholding OAC therapy in
eligible patients need to be investigated.